Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-26 Purchase | 2024-03-28 7:04 pm | IGM Biosciences Inc. | IGMS | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director 10% Owner | 395,317 | $8.6654 | $3,425,569 | 3,753,480 (Indirect) | View |
2023-12-13 Purchase | 2023-12-15 5:32 pm | IGM Biosciences Inc. | IGMS | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director 10% Owner | 532,693 | $6.4417 | $3,431,464 | 3,390,323 (Indirect) | View |
2023-12-13 Purchase | 2023-12-14 6:10 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 101,792 | $221.2 | $22,516,577 | 1,793,403 (Indirect) | View |
2023-12-12 Purchase | 2023-12-14 6:09 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 34,578 | $218.31 | $7,548,616 | 1,699,129 (Indirect) | View |
2023-11-21 Purchase | 2023-11-21 6:15 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 64,350 | $188.47 | $12,128,340 | 1,667,104 (Indirect) | View |
2023-11-17 Purchase | 2023-11-21 6:14 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 67,079 | $178.11 | $11,947,280 | 1,607,668 (Indirect) | View |
2023-11-14 Purchase | 2023-11-15 5:13 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 49,387 | $158.13 | $7,809,559 | 1,545,775 (Indirect) | View |
2023-11-13 Purchase | 2023-11-15 5:12 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 107,499 | $146.99 | $15,801,021 | 1,500,227 (Indirect) | View |
2023-10-19 Sale | 2023-10-23 4:49 pm | Atreca Inc. | BCEL | BAKER BROS. ADVISORS LP BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Former 10% Owner | 274,739 | $0.4025 | $110,582 | 2,971,128 (Indirect) | View |
2023-08-15 Purchase | 2023-08-17 5:08 pm | Neoleukin Therapeutics Inc. | NLTX | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director 10% Owner | 2,285,342 | $0.64038 | $1,463,487 | 5,617,469 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-04-18 07:26 am | N/A N/A | BICYCLE THERAPEUTICS plc | BCYC | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 0 | $0 | 11,723,058 (Indirect) | View |
2024-03-28 Option Award | 2024-04-01 4:26 pm | N/A N/A | INCYTE CORP | INCY | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 543 | $0 | 34,041,354 (Indirect) | View |
2024-03-29 Option Award | 2024-04-01 4:22 pm | N/A N/A | IGM Biosciences Inc. | IGMS | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director 10% Owner | 1,994 | $0 | 3,755,474 (Indirect) | View |
2024-03-28 Option Award | 2024-04-01 08:56 am | N/A 2034-03-27 | Kymera Therapeutics Inc. | KYMR | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 64,000 | $0 | 64,000 (Indirect) | View |
2024-03-12 Option Award | 2024-03-14 4:36 pm | N/A 2034-03-12 | IGM Biosciences Inc. | IGMS | BAKER BROS. ADVISORS LP 667 L.P. BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner | 58,800 | $0 | 58,800 (Indirect) | View |
2024-03-05 Option Award | 2024-03-07 4:53 pm | N/A N/A | vTv Therapeutics Inc. | VTVT | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director | 57,705 | $0 | 3,167,263 (Indirect) | View |
2024-03-05 Disposition | 2024-03-07 4:53 pm | N/A N/A | vTv Therapeutics Inc. | VTVT | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director | 57,657 | $0 | 3,167,263 (Indirect) | View |
Ownership | 2024-03-07 4:50 pm | N/A N/A | vTv Therapeutics Inc. | VTVT | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director | 0 | $0 | 3,175,275 (Indirect) | View |
2023-12-29 Option Award | 2024-01-03 6:02 pm | N/A N/A | IGM Biosciences Inc. | IGMS | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director 10% Owner | 554 | $0 | 3,390,877 (Indirect) | View |
2023-12-29 Option Award | 2024-01-03 5:58 pm | N/A N/A | INCYTE CORP | INCY | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 556 | $0 | 34,040,811 (Indirect) | View |
2023-12-18 Option Award | 2023-12-20 6:43 pm | N/A N/A | Neurogene Inc. | NGNE | BAKER BROS. ADVISORS LP 667 L.P. BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Former 10% Owner Director | 2,877,250 | $0 | 7,831,766 (Indirect) | View |
2023-12-14 Disposition | 2023-12-18 6:46 pm | N/A N/A | Seagen Inc. | SGEN | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Former 10% Owner Director | 44,755,060 | $229 | 0 (Direct) | View |
2023-12-14 Disposition | 2023-12-18 6:46 pm | N/A 2024-05-16 | Seagen Inc. | SGEN | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Former 10% Owner Director | 63,337 | $0 | 0 (Indirect) | View |
2023-12-13 Option Award | 2023-12-13 4:35 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner | 7,936,759 | $3.1499 | 19,532,015 (Indirect) | View |
2023-11-22 Exercise | 2023-11-24 1:39 pm | N/A N/A | BELLICUM PHARMACEUTICALS INC | BLCM | BAKER BROS. ADVISORS LP BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC 10% Owner | 2,116,349 | $0 | 17,674,649 (Indirect) | View |
2023-11-22 Exercise | 2023-11-24 1:39 pm | N/A N/A | BELLICUM PHARMACEUTICALS INC | BLCM | BAKER BROS. ADVISORS LP BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC 10% Owner | 2,116,349 | $0.0001 | 17,674,649 (Indirect) | View |
2023-10-05 Exercise | 2023-10-10 4:22 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director 10% Owner | 592,650 | $0 | 3,363,045 (Indirect) | View |
2023-09-29 Option Award | 2023-10-03 5:33 pm | N/A N/A | IGM Biosciences Inc. | IGMS | BAKER BROS. ADVISORS LP 667 L.P. BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 554 | $0 | 2,896,968 (Indirect) | View |
2023-09-29 Option Award | 2023-10-03 5:32 pm | N/A N/A | INCYTE CORP | INCY | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX Director 10% Owner | 510 | $0 | 34,040,255 (Indirect) | View |
2023-06-30 Option Award | 2023-07-05 5:07 pm | N/A 2033-06-29 | Kodiak Sciences Inc. | KOD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX Director 10% Owner | 80,000 | $0 | 80,000 (Indirect) | View |
2023-06-30 Option Award | 2023-07-05 5:05 pm | N/A N/A | IGM Biosciences Inc. | IGMS | BAKER BROS. ADVISORS LP 667 L.P. BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 554 | $0 | 2,896,414 (Indirect) | View |
2023-06-30 Option Award | 2023-07-05 5:04 pm | N/A N/A | INCYTE CORP | INCY | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX Director 10% Owner | 512 | $0 | 34,039,745 (Indirect) | View |
2023-06-16 Option Award | 2023-06-21 4:47 pm | N/A 2033-06-15 | Prelude Therapeutics Inc | PRLD | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner | 47,000 | $0 | 47,000 (Indirect) | View |
2023-06-15 Option Award | 2023-06-20 5:34 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner | 133,744 | $0 | 11,891,052 (Indirect) | View |
2023-06-15 Option Award | 2023-06-20 4:10 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 4,792 | $0 | 1,401,084 (Indirect) | View |
Ownership | 2023-06-20 06:17 am | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 0 | $0 | 3,914,910 (Indirect) | View |
2023-06-14 Option Award | 2023-06-16 4:02 pm | N/A 2033-06-13 | INCYTE CORP | INCY | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX Director 10% Owner | 25,093 | $0 | 34,061,821 (Indirect) | View |
2023-06-13 Option Award | 2023-06-15 4:40 pm | N/A 2033-06-13 | TScan Therapeutics Inc. | TCRX | BAKER BROS. ADVISORS LP 667 L.P. BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 70,000 | $0 | 70,000 (Indirect) | View |
2023-06-09 Option Award | 2023-06-13 4:52 pm | N/A 2033-06-09 | Talis Biomedical Corp | TLIS | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner | 47,370 | $0 | 47,370 (Indirect) | View |
2023-06-08 Option Award | 2023-06-12 4:03 pm | N/A 2033-06-07 | Neoleukin Therapeutics Inc. | NLTX | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director | 50,000 | $0 | 50,000 (Indirect) | View |